JILLIAN WICKHAM: Open Payments
NPI 1740929579 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 15 payments from 9 companies in 2025. Trend: 2023 $410 · 2024 $349 · 2025 $486
Food & beverage: $311Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 1 | $175 |
| GENZYME CORPORATION | 3 | $83 |
| Karyopharm Therapeutics Inc. | 4 | $74 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $48 |
| Celgene Corporation | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| TerSera Therapeutics LLC | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: ELREXFIO, SARCLISA, XPOVIO, NERLYNX, REBLOZYL, Nubeqa, Zoladex, Enhertu.
Industry payments across IL — which companies pay providers there.
